Top news of the week: 27.10.2020.
World Health Organization, United States, New York City, Oseltamivir, Kirsten Gillibrand, Sample size
Coronavirus
Sex, age, and severity of disease may be useful in identifying #COVID19 survivors who are likely to have high levels of antibodies that can protect against the disease, according to a new study co-led by @SabraKlein1998. https://t.co/s7HPoDYOw5
OpenPatients who had more severe COVID-19 may be the best donors for convalescent plasma therapy
Study links stronger antibody responses to more severe disease, advanced age, and male sex
A team of Chinese researchers has developed a mobile COVID-19 testing lab, allowing people to obtain results within 45 minutes.
It can test 500 to 2,000 people daily and requires only 2 staff members and a driver for its operation https://t.co/wBMQWl1oaY https://t.co/61fiwWrUqP
OpenChina launches mobile COVID-19 testing lab
Staff members work in an inflatable COVID-19 testing lab in Beijing, capital of China, June 23, 2020. A team of researchers from Tsinghua University and the university-affiliated …
Austria reported 3,614 new #COVID19 infections within the past 24 hours, the first time beyond the 3,000-mark since the outbreak of the pandemic in the Alpine country https://t.co/RmueBkkUfg https://t.co/q2CwXNwXfH
OpenAustria reports record new COVID-19 cases
A man wearing a face mask walks on a street in Vienna, Austria, Oct. 21, 2020. (Photo by Georges Schneider/Xinhua) About 60 percent of the coronavirus clusters were associated …
#COVID19 watch, Oct. 23: https://t.co/G3VXixBsmm
- U.S. FDA approves Gilead's remdesivir as COVID-19 treatment
- France's daily cases top 40,000, more regions under curfew
- Chile administers over 4 million tests in total
- Morocco reports highest daily 4,151 new cases https://t.co/ATmrRB7Dy3
OpenLive COVID-19 updates: U.S. FDA approves Gilead's remdesivir as COVID-19 treatment
(Photo by Ting Shen/Xinhua) - U.S. FDA approves Gilead's remdesivir as COVID-19 treatment - France's daily COVID-19 cases top 40,000, more regions under curfew - Chile administers …
Latest #COVID19 watch, Oct. 25: https://t.co/zw3gcvhjOL
- COVID-19 cases surpass one million in Colombia
- WHO donates 8.8 tons of medical supplies to Syria
- Slovenia's daily cases hit new high, FM tests positive
- NYS governor's new book goes hot on Amazon https://t.co/FJS8FendAZ
OpenLive COVID-19 updates: COVID-19 cases surpass one million in Colombia
(Photo by Jhon Paz/Xinhua) - COVID-19 cases surpass one million in Colombia - WHO donates 8.8 tons of COVID-19 medical supplies to Syria - Slovenia's daily cases hit new high, FM …
Fujifilm partners with Carelink Pharmaceutical to sell Avigan in China https://t.co/J8lh7ZfSyM https://t.co/gOoyzwbwdb
OpenFujifilm partners Shanghai firm to seek China COVID-19 approval for Avigan
Japan's Fujifilm Holdings Corp <4901.T> said on Thursday it has partnered with Shanghai-based Carelink Pharmaceutical Co to seek approval in China for Avigan to treat COVID-19 and influenza.
North Korea says China dust could spread COVID-19, warns people to stay inside https://t.co/gKc3PFuOfh https://t.co/3dnXOTHlIb
OpenNorth Korea says China dust could spread COVID-19, warns people to stay inside
North Korea has warned its citizens to stay indoors, saying seasonal yellow dust blowing in from China might carry the new coronavirus into the country.
COVID-19 vaccine development not affected by virus mutation: Chinese official https://t.co/Pux7pPDBTf https://t.co/utYAwEeEo0
OpenCOVID-19 vaccine development unaffected by mutation: Chinese official
China has paid close attention to the issue of virus mutation and has organized more than 30 research institutions nationwide to carry out relevant tracking research, said Tian …